Skip to content

Online intervention to improve intimate relationships for men in substance use treatment

Feasibility of adapting and delivering the ADVANCE technology-enabled intervention to reduce intimate partner abuse by men receiving substance use treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN66619273
Enrollment
60
Registered
2021-10-06
Start date
2021-04-15
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance use and intimate partner abuse Mental and Behavioural Disorders Mental and behavioural disorders due to psychoactive substance use

Interventions

All men will receive substance use treatment as usual plus the ADVANCE digital intervention. The ADVANCE digital intervention consists of: an individual goal setting session
a group video session on the preparation for group
12 self-completion website sessions
12 individual telephone coaching sessions
6 group video sessions and a group video booster session

Sponsors

King's College London
Lead Sponsor
South London and Maudsley NHS Foundation Trust
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria - men receiving community substance use treatment: 1. Male participant has perpetrated abusive or violent behaviour towards a current or ex female partner in the last 12 months 2. Contact with current or ex female partner at least once in the past 4 months – in person, or by phone/text/email/social media 3. Agrees to provide contact details of current and/or ex female (and male partner if bisexual) partner for safeguarding reasons 4. Ability to understand and communicate in English 5. Able to attend the intervention (digital literacy ability to participate, technology and data can be supplied by the research team) 6. Substance use treatment service assesses as suitable to participate in the trial Inclusion criteria – current or ex-female partners of men in the study: 1. Current or ex-partner participating in the study 2. Aged 18 years or older 3. Lives in the UK 4. Ability to understand and communicate in English

Exclusion criteria

Exclusion criteria: Exclusion criteria - men receiving community substance use treatment: 1. Men reporting current order preventing him from contacting current or ex female partner 2. Currently attending an intervention for IPA 3. Previously attended the ADVANCE intervention for IPA 4. Participant is not/ no longer attending the substance use treatment service 5. Other safety concerns that may put the female partner at risk. These will be considered on a case by case basis by the research team and the substance use treatment service e.g. where both participants share a mobile phone number, the male participant has a court case pending for IPA or there is a child protection hearing pending. Exclusion criteria – current or ex-female partners of men in the study: 1. Current order preventing her from contacting current or ex male partner recruited to the study 2. Other safety concerns that may put the male partner at risk. These will be considered on a case by case basis by the research team and the clinical team e.g. where both participants share a mobile phone number, the female participant has a court case pending for IPA or there is a child protection hearing pending. 3. Female partner discloses that there is an order preventing her male current or ex-partner from contacting her (i.e. contradicting what he has said in his screening interview). In such cases the man would not be withdrawn, unless the clinical team felt there was an increased risk to either party in his continuing in the study. Male partners and non-English speaking female partners will not be eligible to take part in the study but will be offered support for their IPA victimisation. If a female partner is excluded because she has a current order preventing her from contacting her current or ex male partner – her current or ex male partner will remain in the study. Selection for suitability will be conducted by substance use service/clinical staff and based on: 1. Meeting the inclusion criteria 2. Not meeting any exclusion criteria 3. Based on specific IPV risk assessment screening (Brief Spousal Assault Form for the Evaluation of Risk (B-SAFER) for male perpetrators

Design outcomes

Primary

MeasureTime frame
Feasibility parameters: The feasibility of adapting the ADVANCE group perpetrator intervention for technology-enabled delivery to men in substance use treatment will be assessed by: 1. Number of men eligible to participate/number of men screened (eligibility rates) 2. Number of men consenting to take part in the study/number of eligible men at screening (recruitment rates men) 3. Number of recruited men completing at least one session of the intervention by the end of the 14-week intervention/number of recruited men (uptake of intervention rates men) 4. Number of current or ex- female partners recruited/number of men recruited (recruitment rates women) 5. Number of women taking up the offer of support from a women’s integrated support service by the end of the 14-week intervention/total number of female partners contacted by integrated support service (uptake of support women) 6. Number of recruited women viewing at least one session of the intervention and safety messages by the end of the 14-week intervention/number of recruited women (uptake of intervention rates women) Acceptability parameters: The acceptability of the technology-enabled ADVANCE intervention to end-users and substance use treatment staff will be assessed at the end of the 14-week intervention by: 1. Number of sessions of the technology-enabled intervention attended (out of a possible goal setting session, 12 website sessions, 12 telephone coaching sessions and 7 video group sessions/ total number of sessions offered (intervention attendance/completion rates for male and female participants) 2. Number of sessions with the integrated support service during the 14-week intervention/ total number of sessions offered (attendance with integrated support service worker rates for female participants) 3. Men’s expe

Secondary

MeasureTime frame
Evaluated for men at 4 post-baseline: 1. Intimate partner abuse (IPA) perpetration assessed in the past 4 months at baseline and 4 months post-baseline using: 1.1. Abusive Behavior Inventory (ABI) - partner form (perpetration) in the previous 4 months 1.2. Controlling Behaviours Scale (partial) in the past 4 months 1.3. Use of social media, stalking, locked in and using children against partner in the past 4 months 2. Substance use measured at baseline and 4 months post men’s baseline using: 2.1. Number of alcohol-free days in past 28 days assessed using the Treatment Outcome Profile 2.2. Number of drug-free days in past 28 days assessed using the Treatment Outcome Profile 3. Mental well-being measured using: 3.1. Depressive symptoms in the past 2 weeks assessed using the PHQ-9 at baseline and 4 months post men’s baseline 3.2. Anxiety symptoms in the past 2 weeks assessed using the GAD-7 at baseline and 4 months post men’s baseline 3.3. PTSD symptoms in the past month assessed using the Primary Care PTSD Screen at baseline and 4 months post men’s baseline 3.4. Propensity for male abusiveness of a female partner in intimate relationships, measured using the Propensity for Abusiveness Scale [anger subscale] at baseline and 4 months post baseline 4. Self-control measured using the Brief Self-Control Scale at baseline and 4 months post baseline 5. Quality of life measured using the EQ-5D-3L at baseline and 4 months post baseline 6. Capability measured using the ICECAP-A at baseline and 4 months post baseline 7. Service use and medication in the past 4 months, measured at baseline and 4 months post baseline To investigate the impact of the ADVANCE intervention in a follow-up study, the following measu

Countries

England, United Kingdom

Contacts

Public ContactJuliet Henderson
Gail.Gilchrist@kcl.ac.uk+44 (0)20 7848 0646

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026